Uric acid and serum antioxidant capacity: A reaction to atherosclerosis?

Atherosclerosis

Volumn 148, Issue 1, 2000, Pages 131-139

  Nieto, F Javier ^a   Iribarren, Carlos ^b   Gross, Myron D ^c   Comstock, George W ^a   Cutler, Richard G ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Genox Corporation   (United States)

Author keywords

Antioxidants; Atheroclerotic disease; Hyperuricemia; Risk factors; Vitamin concentrations

Indexed keywords

ANTIOXIDANT; URIC ACID; VITAMIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; ULTRASOUND; URIC ACID BLOOD LEVEL;

ANTIOXIDANTS; ARTERIOSCLEROSIS; BILIRUBIN; CAROTENOIDS; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RETROSPECTIVE STUDIES; URIC ACID; VITAMINS;

EID: 0033990966     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00214-2     Document Type: Article

References (51)

1. Manson J.A., Gaziano J.M., Jonas M.A., Hennekens C.H. Antioxidants and cardiovascular disease: a review. J. Am. Coll. Nutr. 12:1993;426-432.
2. Hoffman R.M., Garewal H.S. Antioxidants and the prevention of coronary heart disease. Arch. Intern. Med. 155:1995;241-246.
3. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Antioxidants and atherosclerosis heart disease. N. Engl. J. Med. 337:1997;408-416.
4. Street D.A., Comstock G.W., Salkeld R.M., Schuep W., Klag M.J. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation. 90:1994;1154-1161.
5. Stephens N.G., Parsons A., Schofield P.M. et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidants Study (CHAOS). Lancet. 347:1996;781-786.
6. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
7. Hennekens C.H., Buring J.E., Manson J.E. et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasm and cardiovascular disease. N. Engl. J. Med. 334:1996;1145-1149.
8. Rapola J.M., Virtamo J., Haukka J.K. et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double blind, controlled trial. J. Am. Med. Assoc. 275:1996;693-698.
9. Frei B., England L., Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA. 86:1989;6377-6381.
10. Ramirez J., Flowers N.C. Leukocyte ascorbic acid and its relationship to coronary heart disease in man. Am. J. Clin. Nutr. 33:1980;2079-2087.
11. Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 3:1992;194-202.
12. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 78:1981;6858-6862.
13. Sevanian A., Davies K.J., Hochstein P. Conservation of vitamin C by uric acid in blood. J. Free. Rad. Biol. Med. 1:1985;117-124.
14. Emmerson B.T. Atherosclerosis and urate metabolism. Aust. N. Z. J. Med. 9:1979;451-454.
15. The Hypertension Detection and Follow-up Program Cooperative Research Group. Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors. Prev Med 1985;14:312-35.
16. Bengtsson C., Lapidus L., Stendahl C., Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta. Med. Scand. 224:1988;549-555.
17. Iribarren C., Folsom A.R., Eckfeldt J.H., McGovern P.G., Nieto F.J. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study. Ann. Epidemiol. 6:1996;331-340.
18. Yano K., Reed D.M., McGee D.L. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am. J. Epidemiol. 119:1984;653-656.
19. Brand F.N., McGee D.L., Kannel W.B., Stokes J., Castelli W.P. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am. J. Epidemiol. 121:1985;11-18.
20. Freedman D.S., Williamson D.F., Gunter E.W., Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am. J. Epidemiol. 141:1995;637-644.
21. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart. J. 114:1985;413-419.
22. Iribarren C., Sharp D.S., Curb J.D., Yano K. High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers? J. Clin. Epidemiol. 49:1996;673-678.
23. ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives, Am J Epidemiol 1989;129:687-702.
24. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assay for antioxidants. Free. Rad. Biol. Med. 14:1993;303-311.
25. Cao G., Verdon C.P., Wu A.H.B., Wang H., Prior R.L. Automated assay of oxygen-radical absorbance capacity with the COBAS FARA II. Clin. Chem. 41:1995;1738-1744.
26. Perneger T.V., Nieto F.J., Whelton P.K., Klag M.J., Comstock G.W., Szklo M. A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. J. Am. Med. Assoc. 269:1993;488-493.
27. Nieto F.J., Adam E., Sorlie P. et al. A prospective study of cytomegalovirus and other herpes viruses as predictors of subclinical atherosclerosis. Circulation. 94:1996;922-927.
28. Comstock G.W., Menkes M.S., Schober S.E., Vuilleumier J.-P., Helsing K.J. Serum levels of retinol, beta-carotene, and alpha-tocopherol in older adults. Am. J. Epidemiol. 127:1988;114-123.
29. Comstock G.W., Bush T.L., Helzlsouer K.J., Hoffman S.C. The Washington County training center: an exemplar of public health research in the field. Am. J. Epidemiol. 134:1991;1023-1029.
30. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 74:1986;1399-1406.
31. Iribarren C., Folsom A.R., Jacobs D.R., Gross M., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibody against modified LDL with asymptomatic carotid atherosclerosis: the ARIC study. Atheroscler. Thromb. Vasc. Biol. 17:1997;1171-1177.
32. Bieri J.G., Brown E.D., Smith J.C. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J. Liq. Chromatogr. 8:1985;473-484.
33. Craft N.E., Brown E.D., Smith J.C. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin. Chem. 34:1988;44-48.
34. Siedel J., Hägele E.O., Ziegenhorn J., Wahlefeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem. 29:1983;1075-1080.
35. Nagele U., Hagele E.O., Sauer G. et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J. Clin. Chem. Biochem. 22:1984;1075-1080.
36. Nieto FJ, Diez-Roux A, Sxklo M, et al. Short and long term predictors of atherosclerosis by traditional risk factors. J Clin Epidemiol 1999 52:559-67.
37. Mustard JF, Murphy EA, Ogryzlo MA, Smythe HA. et al. Blood coagulation and platelet economy in subjects with primary goat. Can Med Assoc J 1963;89:1207-11.
38. Newland H. Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation. Med. Hypotheses. 1:1975;152-155.
39. Ginsberg M.H., Kozin F., O'Malley M., McCarty D.J. Release of platelet constituents by monosodium urate crystals. J. Clin. Invest. 60:1977;999-1007.
40. Ferris T.F., Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am. J. Med. 44:1968;359-365.
41. Messerli F.H., Frohlich E.D., Dreslinski G.R., Suarez D.H., Aristimuno G.G. Serum uric acid in essential hypertension: an indicator of renal vascular disease. Ann. Intern. Med. 93:1980;817-821.
42. Frohlich E.D. Uric acid. A risk factor for coronary heart disease [Editorial]. J. Am. Med. Assoc. 270:1993;378-379.
43. Lee J., Sparrow D., Vokonas P.S., Landsberg L., Weiss S.T. Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am. J. Epidemiol. 142:1995;288-294.
44. Cappuccio F.P., Strazzullo P., Farinaro E., Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. J. Am. Med. Assoc. 270:1993;354-359.
45. Sevanian A., Davies K.J., Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr. 54:1991;1129-1134.
46. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem. J. 235:1986;747-754.
47. Navab M., Berliner J.A., Watson A.D. et al. The yin and yang of oxidation in the development of the fatty streak: a review based on the George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16:1996;831-842.
48. Stocker R., Glazer A.N., Ames B.N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA. 84:1987;5918-5922.
49. Evans R.W., Shaten B.J., Day B.W., Kuller L.H. Prospective association between lipid soluble antioxidants and coronary heart disease among men in the Multiple Risk Factor Intervention Trial (MRFIT). Am. J. Epidemiol. 147(2):1998;180-186.
50. Comstock G.W., Alberg A.J., Helzlsouer K.J. Reported effects of long-term freezer storage on concentrations of retinol, β-carotene and α-tocopherol in serum or plasma summarized. Clin. Chem. 39:1993;1075-1078.
51. Comstock G.W., Norkus E.P., Hoffman S.C., Xu M.W., Helzlsouer K.J. et al. Stability of ascorbic acid, carotenoids, retinol, and tocopherols in plasma stored at -70°C for 4 years. Can. Epidemiol. Biomarkers. Prev. 4:1995;505-507.